Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
|
Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy |
Hypertension | Phase3 | Japan | NCT06236061 |
|
Kesimpta Pregnancy and Infant Safety Study Using Real World Data |
Multiple Sclerosis | Switzerland | NCT06156683 | |
|
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. |
Glioblastoma | Phase1 |
France Portugal Spain Switzerland United States View All
|
NCT05109728 |
|
Secukinumab Open Label Roll-over Extension Protocol |
Autoimmunity, Inflammation | Phase4 |
Brazil Bulgaria China Colombia Czechia Guatemala India Poland Russian Federation South Africa Spain Switzerland United States View All
|
NCT04638647 |
|
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. |
Primary Prevention of Atherosclerotic Cardiovascular Disease | Phase3 |
Argentina Australia Belgium Brazil Bulgaria Colombia Croatia Czechia Denmark Estonia France Greece Hong Kong India Israel Italy Latvia Lithuania Malaysia Mexico Netherlands Philippines Portugal Romania Singapore Slovakia South Africa Spain Sweden Taiwan Thailand Turkey United Kingdom United States Vietnam View All
|
NCT05739383 |
|
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia |
Breast Cancer | Russian Federation | NCT04943497 |